The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update.
about
Lifestyle-related factors in predementia and dementia syndromesIntranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the artTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseAberrant insulin signaling in Alzheimer's disease: current knowledgeAlzheimer's disease: Unique markers for diagnosis & new treatment modalitiesBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseUncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive DimensionsDiabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation.Effects of fibrillar Aβ(1-40) on the viability of primary cultures of cholinergic neurons and the expression of insulin signaling-related proteins.CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's DiseaseAlzheimer's disease is type 3 diabetes-evidence reviewed.Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?The renin-angiotensin-aldosterone system and Alzheimer s disease?Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's diseaseTriangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedThe Relationship between Metabolic Syndrome and Cognitive Function.Relative intake of macronutrients impacts risk of mild cognitive impairment or dementiaEffects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling.Regulation of beta-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's diseaseInsulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease.Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer's disease.The role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease.Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle.The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy.Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.Glucose Transporters in Brain: In Health and in Alzheimer's Disease.The Diagnosis and Treatment of Behavioral Disorders in Dementia.Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia.Effect of pregabalin on contextual memory deficits and inflammatory state-related protein expression in streptozotocin-induced diabetic mice.Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway.Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.Permissive role of insulin in the expression of long-term potentiation in the hippocampus of immature rats.Association between improvements in insulin resistance and changes in cognitive function in elderly diabetic patients with normal cognitive function.Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil.Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amyloid-β.DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review.
P2860
Q22241490-E7603E17-66EB-4C82-9A13-8E99460AA7D5Q26830845-DFA6285D-33F3-482C-84BA-14FA9076F383Q27021700-882C93D3-2FFB-4C2F-8D7D-CFFD9F1F8AFCQ27024222-50757C6B-9782-4931-8544-83DAB83E7525Q28085139-D2884B60-049D-4EC1-8338-EA34CEE0EBEBQ28259585-278EB08F-F35A-4B97-BDA3-0D1C840EB53AQ30494084-DB3B255D-4371-4202-A354-D3C23650E252Q30998279-E403C195-F5EC-4122-B189-9610684B13B1Q33573761-AB318548-2EEA-4A73-B065-203ADDDABC3FQ33793306-E66AA1FE-977D-4C4E-97AD-F53782BFF288Q33896118-5FAD185E-B1A2-4774-8845-44AA08C8D715Q34020000-0039CD44-666C-4458-AA0F-92761AB0EBD9Q34432135-928F313D-1702-4FC1-8C2A-A7F2245E7FC3Q34669518-34B0D54C-3C17-43F5-9AB0-6D69DFBCDE84Q34814013-D9F33821-F33B-4B89-9292-EAC772306A6BQ35154546-FBBB3E58-ABD7-4E13-B26D-FA167F0E1DD8Q35997824-276259EE-A14E-4F4B-9E74-E99B8B5BA494Q35997884-422876AE-2960-4749-9FEC-0865029FFDE3Q36058383-13584964-9436-424C-85C9-2B219E0DFC62Q36388766-D0BCBBC5-C398-4CFC-BD77-58E85C999CFBQ36964574-8F0D4B51-099F-44B7-AE30-077EB019D8C2Q37069278-117F1BBD-7A4F-44FD-9486-1924C77C2380Q37253971-11E2E553-898F-4305-8152-3EF70D8D4A52Q38034089-012F7A7A-11B0-4A45-AAD0-A67974D16FA4Q38037156-649B1DD6-B977-47A1-92BB-DE6ECA173BCAQ38064315-0D84A602-340A-4848-857B-CB3E0F913F71Q38171298-C3A57D37-7670-4C70-9E6A-B9C50B7D27C8Q38352298-04DEB63B-33D1-477C-959A-8688E874B56BQ38601445-C3DE2503-6C67-40F1-8F80-0BE2E2DF6199Q39012005-B7304FB9-19DB-4F03-8ADE-280531956F31Q39433366-BDFCCA66-6F4A-405C-B3B8-BF4619F2E54BQ41203727-6E399E74-B263-4420-BE0E-F9BE89D9585DQ41568885-858E3F94-9735-4244-B1F7-CC73D1108E0DQ42164668-C59D9B83-8B75-4C96-BEF2-C24A499C1720Q42715359-4FAA87E2-CBF9-4403-8D14-D0144B8224F1Q42749214-27437B22-0FDF-466E-B132-80A96425B28DQ43905005-EEC9E0D0-908B-4AA9-8351-9A609AA5DF33Q46798716-5E1A05B0-F9C2-4441-A5A6-48192F38C710Q47963951-96742126-C978-4116-8335-1C090C676EB2Q48178356-D1B4A4C9-DE6B-4AE2-AD0F-5C7A6E6E79F5
P2860
The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The brain insulin signal trans ...... Alzheimer disease: an update.
@ast
The brain insulin signal trans ...... Alzheimer disease: an update.
@en
The brain insulin signal transduction system and sporadic
@nl
type
label
The brain insulin signal trans ...... Alzheimer disease: an update.
@ast
The brain insulin signal trans ...... Alzheimer disease: an update.
@en
The brain insulin signal transduction system and sporadic
@nl
prefLabel
The brain insulin signal trans ...... Alzheimer disease: an update.
@ast
The brain insulin signal trans ...... Alzheimer disease: an update.
@en
The brain insulin signal transduction system and sporadic
@nl
P356
P1476
The brain insulin signal trans ...... Alzheimer disease: an update.
@en
P2093
P2888
P304
P356
10.1007/S007020200028
P577
2002-03-01T00:00:00Z